ArticleTransplantation research2016

Immunomodulating effects of the anti-viral agent Silibinin in liver transplant patients with HCV recurrence.

Antonino Castellaneta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.